FGEN vs. DHC

In the year-to-date period, FGEN achieves a -42.17% return, which is significantly lower than DHC's 7.01% return. Over the past 10 years, FGEN has underperformed DHC with an annualized return of -36.99%, while DHC has yielded a comparatively higher -15.14% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for FibroGen, Inc. (FGEN) and Diversified Healthcare Trust (DHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FGEN Sharpe Ratio is -0.69, which is lower than the DHC Sharpe Ratio of 0.10. The chart below compares the historical Sharpe Ratios of FGEN and DHC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FGEN has not paid dividends to shareholders, while DHC's dividend yield for the trailing twelve months is around 1.63%.

The maximum FGEN drawdown since its inception was -99.56%, roughly equal to the maximum DHC drawdown of -96.18%. Use the drawdown chart below to compare losses from any high point for FGEN and DHC. For additional features, visit the drawdowns tool.

FibroGen, Inc. (FGEN) has a higher volatility of 38.30% compared to Diversified Healthcare Trust (DHC) at 13.37%. This indicates that FGEN's price experiences larger fluctuations and is considered to be riskier than DHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between FibroGen, Inc. and Diversified Healthcare Trust. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.